Advertisement
Screener

Dolby Laboratories, Inc. (DLB) Operating Lease, Payments

2.8 / 5 stars · 68/120 Roast Me

Dolby Laboratories, Inc. Operating Lease, Payments

Dolby Laboratories, Inc. (DLB) reported Operating Lease, Payments of $14.86 million for the 12-month period ending 2025-09-26, per its 10-K filed 2025-11-18.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:OperatingLeasePayments · last filed 2025-11-18

  • Dolby Laboratories, Inc. operating lease, payments for the quarter ending 2022-12-30 was $3.83M, a 18.51% decline year-over-year.
  • Dolby Laboratories, Inc. operating lease, payments for the quarter ending 2022-09-30 was $3.81M, a 20.74% decline year-over-year.
  • Dolby Laboratories, Inc. operating lease, payments for the quarter ending 2022-07-01 was $3.88M, a 9.69% decline year-over-year.
  • Dolby Laboratories, Inc. operating lease, payments for the quarter ending 2022-04-01 was $4.57M, a 11.18% decline year-over-year.
  • Dolby Laboratories, Inc. operating lease, payments for fiscal 2025 was $14.86M, a 4.74% decline from fiscal 2024.
  • Dolby Laboratories, Inc. operating lease, payments for fiscal 2024 was $15.60M, a 5.95% decline from fiscal 2023.
  • Dolby Laboratories, Inc. operating lease, payments for fiscal 2023 was $16.59M, a 2.17% decline from fiscal 2022.
  • Dolby Laboratories, Inc. operating lease, payments for fiscal 2022 was $16.96M, a 11.56% decline from fiscal 2021.
Period endOperating Lease, Payments 3 monthOperating Lease, Payments 6 monthOperating Lease, Payments 9 monthOperating Lease, Payments 12 month
2025-09-26$14.86M
10-K · filed 2025-11-18
2024-09-27$15.60M
10-K · filed 2025-11-18
2023-09-29$16.59M
10-K · filed 2025-11-18
2022-12-30$3.83M
10-Q · filed 2023-02-02
$7.63M
derived: sum of 2 quarters · filed 2024-11-19
$11.52M
derived: sum of 3 quarters · filed 2024-11-19
$16.09M
derived: sum of 4 quarters · filed 2024-11-19
2022-09-30$3.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-19
$7.70M
derived: sum of 2 quarters · filed 2024-11-19
$12.26M
derived: sum of 3 quarters · filed 2024-11-19
$16.96M
10-K · filed 2024-11-19
2022-07-01$3.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-09
$8.45M
derived: sum of 2 quarters · filed 2022-08-09
$13.15M
10-Q · filed 2022-08-09
$17.95M
derived: sum of 4 quarters · filed 2023-11-17
2022-04-01$4.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-05
$9.26M
10-Q · filed 2022-05-05
$14.07M
derived: sum of 3 quarters · filed 2023-11-17
$18.37M
derived: sum of 4 quarters · filed 2023-11-17
2021-12-31$4.69M
10-Q · filed 2023-02-02
$9.50M
derived: sum of 2 quarters · filed 2023-11-17
$13.80M
derived: sum of 3 quarters · filed 2023-11-17
$18.95M
derived: sum of 4 quarters · filed 2023-11-17
2021-09-24$4.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-17
$9.11M
derived: sum of 2 quarters · filed 2023-11-17
$14.25M
derived: sum of 3 quarters · filed 2023-11-17
$19.17M
10-K · filed 2023-11-17
2021-06-25$4.30M
10-Q · filed 2021-07-29
$9.45M
derived: sum of 2 quarters · filed 2021-07-29
$14.37M
10-Q · filed 2022-08-09
$19.94M
derived: sum of 4 quarters · filed 2022-11-18
2021-03-26$5.14M
10-Q · filed 2021-05-04
$10.06M
10-Q · filed 2022-05-05
$15.63M
derived: sum of 3 quarters · filed 2022-11-18
$21.34M
derived: sum of 4 quarters · filed 2022-11-18
2020-12-25$4.92M
10-Q · filed 2022-02-04
$10.49M
derived: sum of 2 quarters · filed 2022-11-18
$16.20M
derived: sum of 3 quarters · filed 2022-11-18
$21.72M
derived: sum of 4 quarters · filed 2022-11-18
2020-09-25$5.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-18
$11.28M
derived: sum of 2 quarters · filed 2022-11-18
$16.80M
derived: sum of 3 quarters · filed 2022-11-18
$22.04M
10-K · filed 2022-11-18
2020-06-26$5.71M
10-Q · filed 2021-07-29
$11.23M
derived: sum of 2 quarters · filed 2021-07-29
$16.47M
10-Q · filed 2021-07-29
2020-03-27$5.53M
10-Q · filed 2021-05-04
$10.77M
10-Q · filed 2021-05-04
2019-12-27$5.24M
10-Q · filed 2021-01-29